Since NRF2 can be activated by post-translational modification such as phosphorylation by various protein kinases (11), it is plausible that activation of NRF2 is mediated by oncogenic activation of upstream signaling pathway in cancer cells. The gene discussed is NFE2L2; the disease is cancer.